Does TACROLIMUS Cause Hyperammonaemia? 181 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 181 reports of Hyperammonaemia have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
181
Reports of Hyperammonaemia with TACROLIMUS
0.2%
of all TACROLIMUS reports
100
Deaths
117
Hospitalizations
How Dangerous Is Hyperammonaemia From TACROLIMUS?
Of the 181 reports, 100 (55.2%) resulted in death, 117 (64.6%) required hospitalization, and 74 (40.9%) were considered life-threatening.
Is Hyperammonaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 181 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Hyperammonaemia?
VALPROIC ACID (581)
VALPROATE (328)
FLUOROURACIL (263)
DIVALPROEX (256)
LEVETIRACETAM (192)
ACETAMINOPHEN (177)
OXALIPLATIN (160)
TOPIRAMATE (156)
GLYCEROL PHENYLBUTYRATE (147)
METHOTREXATE (126)
Which TACROLIMUS Alternatives Have Lower Hyperammonaemia Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB